• Developed scripts and ETL pipelines using Python to facilitate data import for users transitioning to the Albert platform.

• Collaborated with clients to create custom integrations utilizing AWS Lambda and Python, enhancing their experience with the platform.

• Generated complex SQL reports with MySQL, significantly improving reporting capabilities within the Albert platform.

• Developed and optimized scalable ETL pipelines using SQL and Scala, processing both batch and streaming data with Apache Spark and Kafka.

• Implemented data modeling and transformation logic to improve dataset reliability, performance, and downstream analytical usability.

• Implemented data modeling and transformation logic to improve dataset reliability, performance, and downstream analytical usability.

• Ensured data quality and pipeline reliability through validation checks, troubleshooting, and performance tuning.

• Contributed to an agile development environment, participating in code reviews, sprint planning, and Jira-based workflow management.

• Developed plugins for the bioinformatics software Geneious Prime which allowed users to quickly validate and optimize nucleotide sequences using Python.

• Designed and implemented a Java-based front-end interface, enhancing user experience for sequence analysis results.

• Collaborated with cross-functional teams in an Agile environment to develop software solutions, utilizing excellent written and verbal communication skills to effectively convey technical information to both technical and non-technical stakeholders.

• Developed chromatography (affinity/SEC) and filtration (TFF) unit operations for the pre-clinical downstream purification process for 24 different mRNA molecules.

• Authored process description and batch record documentation to facilitate manufacturing tech transfer initiatives.

• Composed technical presentations using data gathered from experiments and presented them to directors to assess process viability.

• Improved automation capabilities for chromatography operations to reduce turnaround time by 25%.

• Implemented optimizations to unit operations to increase drug substance yield by 12% by altering operating conditions.

• Oversaw a suite of 5 research initiatives, conducting chromatography (affinity/IEX) and filtration studies for purification of therapeutic proteins in early and late-stage development to improve downstream manufacturing processes.

• Designed process flow diagrams for scaling up bench top purification processes for use in manufacturing.

• Developed and executed verification testing protocols to ensure compliance with regulatory standards and improve product quality.